News & Info

March 1, 2011

Maintaining Independence and Quality of Life

Posted in: Daily Living, Latest News, Low Vision Rehabilitation

by Dan Roberts March 2011 The “English Longitudinal Study of Ageing” has found that people with poor eyesight are three to five times more likely than those with good eyesight to suffer from low quality of life, poor psychological health, and depression.1 When those inequalities are accounted for, however, the impact of poor eyesight itself
read more »

February 10, 2011

“Crossing The Line From Visual To Nonvisual Skills”

Posted in: Daily Living, Low Vision Rehabilitation

An Interview with Maurice Peret (Blind Industries and Services of Maryland) Dan Roberts, Moderator International Low Vision Support Group February 10, 2011 Dan: Welcome to our webcast, Maurice. Please tell us how you became blind and how that led you into your work as rehabilitation trainer for Blind Industries and Services of Maryland. Maurice: How
read more »

September 14, 2010

A Primer on the Use of Stem Cells in Ophthalmology

Posted in: Research and Developments

Irving J. Arons September 2, 2010 (Version 3, Updated September 14, 2010) I recently came across an interesting news release from International Stem Cell Corporation (ISCO) announcing that it had formed a new business unit, Cytovis, to focus on stem cell programs in ophthalmology, including CytoCor for the cornea and CytoRet for the retina. That
read more »

July 22, 2010

Spikes in IOP May Result From Particulate Matter in Avastin

Posted in: Research and Developments

by Dan Roberts In a presentation to Hawaiian Eye 2010, Malik Y. Kahook, MD, said that Avastin (bevacizumab) stored for long periods of time shows evidence of increased large particulate matter. This debris can block the eye’s trabecular network and lead to increased intraocular pressure (IOP) in patients being treated with the drug for wet
read more »

June 1, 2010

Summary of Research and Developments in Macular Degeneration: 2009-2010

Posted in: Research and Developments

by Dan Roberts June 10, 2010 Introduction If I were to describe the past twelve months in a word, it would be “progress.” No spectacular breakthroughs have occurred during that time to make big news in the AMD world, but a lot of persistent work has been reaping promising results. moving us ever closer to
read more »

May 23, 2010

Dominant Drusen

Posted in: Eye Conditions

by Dan Roberts (Updated May 2010) Dominant Drusen is an inherited autosomal dominant condition that presents with small round white retinal spots (drusen) that eventually form into a honeycomb pattern in the area of the optic disc and macula. Vision loss is usually slow unless neovascularization (abnormal blood vessel growth and leakage) occurs. Dominant drusen
read more »

May 16, 2010

Genetic testing sheds light on degenerative eye disease

Posted in: Latest News, Research and Developments

Press Release February 13, 2007 Updated 5/16/2010 ANN ARBOR, Mich. — Genetic testing for eye disease is providing vital information about complex retinal diseases, especially when used to confirm a clinician’s diagnosis. In a newly published review of such tests that were conducted over a five-year period at the University of Michigan Kellogg Eye Center,
read more »

February 8, 2010

Saffron Shown to Improve Vision

Posted in: Health and Nutrition, Latest News

by Dan Roberts February 8, 2010 Clinical trials in Italy and Australia have shown that the spice, saffron, can improve vision in people with AMD. The trial was conducted Policlinico Gemelli in Italy by Professor Benedetto Falsini. It was double blind and randomly controlled, involving 25 subjects over six months. Half the group was given
read more »

February 3, 2010

Study Shows Lucentis and Avastin to be Equal

Posted in: Latest News, Research and Developments

by Dan Roberts February 3, 2010 Investigators at Kaiser Permanente Southern California in Pasadena reported in the February 2010 issue of Ophthalmology that Avastin and Lucentis performed equally in recent testing. In an indirect comparison of the two drugs, study author Dr. Donald Fong and coauthors reviewed the records of 452 patients treated for wet
read more »

January 30, 2010

PEG-POD – New Gene Delivery Tool

Posted in: Latest News, Research and Developments

by Dan Roberts January 2010 Researchers have developed a new tool for gene therapy that significantly increases gene delivery to cells in the retina compared to other carriers and DNA alone. The study was published in the January 2010 issue of The Journal of Gene Medicine by Tufts University School of Medicine and the Sackler
read more »

January 28, 2010

Foresee Home Sets New Standard of Care for AMD Patients

Posted in: Therapies, Treatments, and Procedures

by Dan Roberts Updated 3/1/2016 A relatively new technology, called preferential hyperacuity perimetry (PHP) allows eye doctors to detect progression in AMD sooner than with the Amsler grid. The key to the best outcome for treatment of wet AMD is early diagnosis and treatment. The ForeseeHomeª AMD Monitor by Notal Vision is approved by the
read more »

November 30, 2009

Blue Light Filtering IOLs May Slow AMD

Posted in: Research and Developments

by Dan Roberts November 2009 A 2009 study* has shown that implantation of a blue light-filtering intraocular lens (IOL) at the time of cataract surgery increases macular pigment in the retina. This increase may provide protection against the development and/or progression of AMD. The study was reported by the Macular Pigment Research Group at the
read more »

October 27, 2009

Brachytherapy May Reduce Burden of Treatment and Further Improve Visual Acuity

Posted in: Research and Developments, Therapies, Treatments, and Procedures

San Francisco, CA (PRWEB) October 27, 2009 — NeoVista, Inc. made public at the American Academy of Ophthalmology meeting the company’s interim study results from the preliminary study MERITAGE-I. The study was designed to examine the company’s novel epimacular brachytherapy procedure when used in patients that require chronic anti-VEGF treatment for wet AMD. Brachytherapy involves
read more »

August 25, 2009

Driving Safely

Posted in: Daily Living

by Edward J. Huggett, O.D. Originally published August 2009 I am often asked, “How long is it safe to drive when your vision is deteriorating?” There are three visual factors that are important to consider when it comes to driving. Visual acuity (VA), visual field (VF) and contrast sensitivity (CS). There are others I will
read more »

June 17, 2009

Lipschitz Macular Implant Allows Bilateral Magnification of Vision

Posted in: Research and Developments

On June 17, 2009, OptoLight Vision Technology announced that it received a CE mark for its Lipshitz Macular Implant (LMI), named for its inventor, Isaac Lipshitz. This will allow OptoLight to immediately begin marketing the implant in Europe and other markets outside of the United States. On December 28, 2007, Optolight Vision Technology announced success
read more »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann